Platelets and Thrombopoiesis
Overview of Platelets and Their Functions
Platelets are critical components in the hemostatic process, primarily functioning to prevent or stop blood loss following vascular injury.
Learning Outcomes
By the end of the session, students should be able to:
Describe the role and function of platelets.
Describe the structure of platelets, including internal and external components.
Explain the process of thrombopoiesis.
Differentiate between quantitative and qualitative platelet abnormalities with emphasis on thrombocytopenia and thrombocytosis.
Understand the risks associated with low or high platelet counts.
Role and Functions of Platelets
Prevent or stop blood loss after vascular injury.
Engaged in primary hemostasis:
Formation of the platelet plug, which is stabilized by fibrin through activation of the coagulation system.
Adherence to the damaged vascular area, aggregation (attraction of more platelets), and activation (release of granules).
Beyond hemostasis, they are also involved in:
Inflammation
Immunity
Angiogenesis
Carcinogenesis
Structure of Platelets
Size: Platelets are typically 2-4 microns in diameter.
Mean platelet volume is used to assess their average size.
Platelets are derived from megakaryocytes via a process called thrombopoiesis.
Key structural components:
A nucleate: Lack of nucleus similar to mature red blood cells; only white blood cells possess nuclei.
Phospholipid bilayer membrane:
Characterized by polar heads facing outward and non-polar fatty acids oriented inward, with cholesterol for stabilization.
Surface receptors for adhesion and participation in immune reactions.
Internal Components of Platelets
Granules:
Alpha granules: Most abundant, containing substances crucial for adhesion, aggregation, and coagulation, numbered between 50-80 per platelet.
Dense granules: Fewer in number (2-7 per platelet); contain ADP, ATP, serotonin, and calcium, important for coagulation and platelet activation.
Other organelles:
Mitochondria
Glycogen
Peroxisomes
Lysosomes
Microtubules and surface-connected canalicular system facilitate granule release and increase surface area for reactions.
Thrombopoiesis
Thrombopoiesis is regulated by Thrombopoietin:
Also known as megakaryocyte growth and development factor.
Predominantly synthesized in the liver, kidney, and bone marrow.
Mechanism:
Binds to the membrane receptor MPL, activating pathways for cell survival and proliferation.
Inverse relationship between serum thrombopoietin levels and platelet count.
Low platelet count increases thrombopoietin production; high platelet count decreases it.
Process:
Megakaryoblast undergoes maturation into promegakaryocyte under thrombopoietin influence, eventually differentiating into a megakaryocyte with visible cytoplasmic granules.
The megakaryocyte sheds pro platelets into circulation through cytoplasmic fragmentation, effectively forming platelets.
Quantitative and Qualitative Abnormalities
Quantitative Thrombocytopenia and Thrombocytosis
Thrombocytopenia: Platelet count below the reference range, graded by severity:
Increased risk of bleeding, bruising, purpura, and petechiae as count drops; noted that below 20, risk for spontaneous bleeding rises.
Thrombocytosis: Platelet count above the reference range, associated risks:
Higher count correlates with increased risk of thrombosis; can be divided into reactive or malignancy-related thrombocytosis.
Key causes of thrombocytopenia:
Decreased production due to conditions affecting bone marrow (e.g., chemotherapy).
Increased loss due to hemorrhage or dilution.
Increased consumption, resulting from clot formation within blood vessels (either normal or pathological).
Increased destruction, immune-mediated or not.
Qualitative Abnormalities
Qualitative platelet disorders exist when the number is low, normal, or high, impacting functionality rather than quantity.
Common causes include inherited disorders or drug-induced dysfunction (e.g., aspirin).
Summary and Key Takeaways
Major functions of platelets involve preventing blood loss through the formation and stabilization of blood clots during hemostasis.
Key components include membrane structures, granules, and the thrombopoiesis process regulated by thrombopoietin.
Understanding quantitative abnormalities (thrombocytopenia and thrombocytosis) is essential for assessing patient risks in clinical settings.
Qualitative disorders will be explored in further detail in the next semester.